JOMPAC

Journal of Medicine and Palliative Care (JOMPAC) is an open access scientific journal with independent, unbiased, and double-blind review under international guidelines. The purpose of JOMPAC is to contribute to the literature by publishing articles on health sciences and medicine.

EndNote Style
Index
Original Article
Clinical outcomes of palliative 3-dimensional conformal external beam gastric radiotherapy: single center experience
Aims: Patients diagnosed with locally advanced and/or metastatic gastric cancer and who cannot undergo surgery may need palliative treatment during their follow-up. There is scarce data about outcomes of palliative gastric radiotherapy (RT). In this study, we aimed to investigate the effect of 3-D external beam RT on oncological outcomes, as a non-invasive method. Material and
Methods: From 2013 to 2017, sixteen gastric cancer patients treated with palliative external RT in our institutional clinic were evaluated. Only patients who received palliative gastric radiotherapy for obstruction, pain and bleeding were analyzed, and patients who had previously received RT to the abdomen or who were given RT for adjuvant purposes were not included in the analysis.
Results: Seven patients (43%) were not able to finish the planned palliative course. Thirty Gray with 10 fractions was the most planned RT schedule. Almost half of the patients (%56) received chemotherapy before RT. Overall survival was found to be median 2 months. Median survival was better in patients who were able to receive 28 Gy bioequivalent dose (4 vs 0.3 months, p?0.00). Purpose of palliation also found to be a significant factor on survival. Patients who were referred for pain have found to be better survival rather than bleeding and obstruction (13 vs 0.7 months, p=0.03).
Conclusion: External radiotherapy is an easily applicable and effective method for palliation in gastric cancer patients. Early referral for radiotherapy in patients who need alliation may increase oncological outcomes. It has been observed that the prognosis is worse in patients who received palliative radiotherapy due to gastric bleeding and obstruction.


1. Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020:GLOBOCAN Estimates of Incidence and Mortality Worldwidefor 36 Cancers in 185 Countries CA: A Cancer Journal forClinicians 2021; 71: 209-249.
2. Wanebo HJ, Kennedy BJ, Chmiel J, Steele G Jr, Winchester D, OsteenR. Cancer of the stomach. A patient care study by the AmericanCollege of Surgeons. Ann Surg 1993; 218: 583-92.
3. Allum WH, Powell DJ, McConkey CC, Fielding JW. Gastriccancer: a 25-year review. British J Surg 1989; 76: 535-40.
4. Kim MM, Rana V, Janjan NA, et al. Clinical benefit of palliativeradiation therapy in advanced gastric cancer. Acta Oncologica2008; 47: 421-27.
5. Hashimoto K, Mayahara H, Takashima A, et al. Palliativeradiation therapy for hemorrhage of unresectable gastric cancer:a single institute experience. J Cancer Res Clin Oncol 2009; 135:1117-23.
6. Lee JA, Lim DH, Park W, Ahn YC, Huh SJ. Radiation therapy forgastric cancer bleeding. Tumori 2009; 95: 726-30.
7. Asakura H, Hashimoto T, Harada H, et al. Palliative radiotherapyfor bleeding from advanced gastric cancer: is a schedule of 30Gy in 10 fractions adequate? J Cancer Res Clin Oncol 2011; 137:125-30
8. Chaw CL, Niblock PG, Chaw CS, Adamson DJ. The role ofpalliative radiotherapy for haemostasis in unresectable gastriccancer: a single-institution experience. Ecancermedicalscience2014; 8: 384.
9. Tey J, Choo BA, Leong CN, et al. Clinical outcome of palliativeradiotherapy for locally advanced symptomatic gastric cancer inthe modern era. Medicine 2014; 93: e118.
10. Kondoh C, Shitara K, Nomura M, et al. Efficacy of palliativeradiotherapy for gastric bleeding in patients with unresectableadvanced gastric cancer: a retrospective cohort study. BMCPalliat Care 2015; 14: 37.
11. Takeda K, Sakayauchi T, Kubozono M, et al. Palliativeradiotherapy for gastric cancer bleeding: a multi-institutionalretrospective study. BMC Palliat Care 2022; 21: 52.
12. Mitsuhashi N, Ikeda H, Nemoto Y, Kuronuma M, Kamiga M,Hiroshima Y. Hemostatic effect of palliative radiation therapy inpreventing blood transfusions from bleeding occurring withinadvanced gastric cancer. Palliat Med Rep 2021; 2: 355-64.
13. Kim YI, Choi IJ. Endoscopic management of tumor bleedingfrom inoperable gastric cancer. Clin Endosc 2015; 48: 121-7.
14. Kamarajah SK, Markar SR, Phillips AW, Salti GI, DahdalehF, Griffiths EA. Palliative gastrectomy for metastatic gastricadenocarcinoma: a national population-based cohort study.Surgery 2021; 170: 1702-10.
15. Manfredi S, Dior M, Bouche O, et al. Daily practices inchemotherapy for advanced gastric or gastroesophageal junctionadenocarcinoma: METESTOMAC French prospective cohort.Cancer Med 2022; 10: 1002.
16. Halpern AL, McCarter MD. Palliative management of gastric andesophageal cancer. Surg Clin North Am 2019; 99: 555-69.
17. Lee YH, Lee JW, Jang HS. Palliative external beam radiotherapyfor the treatment of tumor bleeding in inoperable advancedgastric cancer. BMC Cancer 2017; 17: 541.
18. Tey J, Soon YY, Koh WY et al. Palliative radiotherapy for gastriccancer: a systematic review and meta-analysis. Oncotarget 2017;8: 25797-805
19. Inoue T. Successful palliative radiotherapy for malignant cardiacobstruction caused by gastric cancer. Cureus 2022; 14: e27466.
20. Cooper JS, Guo MD, Herskovic A, et al. Chemoradiotherapy oflocally advanced esophageal cancer: long-term follow-up of aprospective randomized trial (RTOG 85-01). Radiation TherapyOncology Group. JAMA 1999; 281: 1623-7.
21. Herskovic A, Martz K, al-Sarraf M, et al. Combined chemotherapyand radiotherapy compared with radiotherapy alone in patientswith cancer of the esophagus. N Engl J Med 1992; 326: 1593-8.
22. Penniment MG, De Ieso PB, Harvey JA, et al. Palliativechemoradiotherapy versus radiotherapy alone for dysphagiain advanced oesophageal cancer: a multicentre randomisedcontrolled trial (TROG 03.01). Lancet Gastroenterol Hepatol2018; 3: 114-124.
Volume 4, Issue 1, 2023
Page : 46-50
_Footer